Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.50p
   
  • Change Today:
      0.050p
  • 52 Week High: 11.75
  • 52 Week Low: 5.75
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 0
  • Market Cap: £15.77m
  • RiskGrade: 429
  • Beta: 0.04

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Lorenzo Gallon, James Renwick McCullough, Erik Kristian Lium

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 6.50p
Change Today 0.050p
% Change 0.78 %
52 Week High 11.75
52 Week Low 5.75
Volume 0
Shares Issued 242.54m
Market Cap £15.77m
Beta 0.04
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.17% below the market average54.17% below the market average54.17% below the market average54.17% below the market average54.17% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Price Trend
63.22% below the market average63.22% below the market average63.22% below the market average63.22% below the market average63.22% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page